[Webinar] How Can Adaptive Designs and Master Protocols Enhance Your Oncology Trials?
While oncology trials comprise a large proportion of current research pipelines, conventional oncology development programs are frequently expensive, inefficient, and [...]
Cytel Scientists Call for a “Statistician-First Workflow” to Optimize Drug Development
Adaptive trial designs within oncology are described by Cytel scientists, and address data, statistical, and commercial and scientific value of [...]
Advertisement
